Lilly Collaborates with DexCom to Utilize Dexcom CGM in its Personalized Diabetes Management System

 Lilly Collaborates with DexCom to Utilize Dexcom CGM in its Personalized Diabetes Management System

Lilly Collaborates with DexCom to Utilize Dexcom CGM in its Personalized Diabetes Management System

Shots:

  • Lilly enters into a non-exclusive commercialization agreement with DexCom to integrate Dexcom’s CGM device in both the pen- and pump-based platforms, designed to improve diabetes management
  • The collaboration will integrate connected insulin delivery devices, software and analysis to aid patients with T1D and T2D and provide personalized information to HCPs to simplify diabetes management
  • The pen-based platform is to integrate personalized data from a prefilled, disposable insulin pen with data from glucose-sensing technologies into an app while the pump-based platform is used to integrate insulin pump, CGM and a handheld controller or an app controlling the system to automate insulin dosing

Click here to­ read full press release/ article | Ref: Eli Lilly | Image: cbs4indy             

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post